Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Drug and Alcohol Dependence
|
February 3, 2025
Real-world access to buprenorphine treatment in Philadelphia: A secret shopper study
Margaret Lowenstein, M Holliday Davis, Shoshana V Aronowitz, et al.
Substance Use & Addiction Journal
|
October 21, 2025
Exploring the Perspectives of Peer Recovery Specialists: Needs for Training, Support, and Professional Development
Margaret Lowenstein, Kathryn Gallagher, Nicole O'Donnell, et al.
Addiction Science & Clinical Practice
|
June 24, 2023
"I wouldn't need Narcan for myself, but I can have it for somebody else:" perceptions of harm reduction among hospitalized patients with OUD
Rachel French, M Holliday Davis, Shoshana V Aronowitz, et al.
Research Square
|
April 8, 2025
"The community's memory is timeless", Exploring Cultural and Community Context to Inform the Public Health Response to the Overdose Crisis in Black Communities
Jasmine Barnes, M Holliday Davis, Kathryn Gallagher, et al.
JAMA Network Open
|
June 16, 2026
Policy and Payment Factors Influencing Adoption of Low-Barrier Buprenorphine Treatment
Margaret Lowenstein, M Holliday Davis, Selena Suhail-Sindhu, et al.
The International Journal on Drug Policy
|
September 6, 2024
Barriers and facilitators to implementing CareConnect: A telehealth, low-barrier buprenorphine bridge clinic in Philadelphia
Shoshana V Aronowitz, M Holliday-Davis, Rachel French, et al.
Harm Reduction Journal
|
April 30, 2026
"The community's memory is timeless": exploring cultural and community context to inform the public health response to the overdose crisis in black communities
Jasmine Barnes, M Holliday Davis, Kathryn Gallagher, et al.
Journal of Addiction Medicine
|
February 3, 2025
Exploring Preferences for Communication and Care among Hospitalized Patients with Opioid Use Disorder: A Qualitative Descriptive Study
M Holliday Davis, Rachel French, Molly Crowe, et al.
JAMA Dermatology
|
November 13, 2024
Wound Characteristics Among Patients Exposed to Xylazine
Lydia Lutz, Rachel McFadden, Lin Xu, et al.
Drug and Alcohol Dependence
|
May 7, 2025
Manifestations of potential xylazine withdrawal: A retrospective cohort study with nested case series
Ashish P Thakrar, Samantha J Zwiebel, Paul J Christine, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Drug and Alcohol Dependence
|
February 3, 2025
Real-world access to buprenorphine treatment in Philadelphia: A secret shopper study
Margaret Lowenstein, M Holliday Davis, Shoshana V Aronowitz, et al.
Substance Use & Addiction Journal
|
October 21, 2025
Exploring the Perspectives of Peer Recovery Specialists: Needs for Training, Support, and Professional Development
Margaret Lowenstein, Kathryn Gallagher, Nicole O'Donnell, et al.
Addiction Science & Clinical Practice
|
June 24, 2023
"I wouldn't need Narcan for myself, but I can have it for somebody else:" perceptions of harm reduction among hospitalized patients with OUD
Rachel French, M Holliday Davis, Shoshana V Aronowitz, et al.
Research Square
|
April 8, 2025
"The community's memory is timeless", Exploring Cultural and Community Context to Inform the Public Health Response to the Overdose Crisis in Black Communities
Jasmine Barnes, M Holliday Davis, Kathryn Gallagher, et al.
JAMA Network Open
|
June 16, 2026
Policy and Payment Factors Influencing Adoption of Low-Barrier Buprenorphine Treatment
Margaret Lowenstein, M Holliday Davis, Selena Suhail-Sindhu, et al.
The International Journal on Drug Policy
|
September 6, 2024
Barriers and facilitators to implementing CareConnect: A telehealth, low-barrier buprenorphine bridge clinic in Philadelphia
Shoshana V Aronowitz, M Holliday-Davis, Rachel French, et al.
Harm Reduction Journal
|
April 30, 2026
"The community's memory is timeless": exploring cultural and community context to inform the public health response to the overdose crisis in black communities
Jasmine Barnes, M Holliday Davis, Kathryn Gallagher, et al.
Journal of Addiction Medicine
|
February 3, 2025
Exploring Preferences for Communication and Care among Hospitalized Patients with Opioid Use Disorder: A Qualitative Descriptive Study
M Holliday Davis, Rachel French, Molly Crowe, et al.
JAMA Dermatology
|
November 13, 2024
Wound Characteristics Among Patients Exposed to Xylazine
Lydia Lutz, Rachel McFadden, Lin Xu, et al.
Drug and Alcohol Dependence
|
May 7, 2025
Manifestations of potential xylazine withdrawal: A retrospective cohort study with nested case series
Ashish P Thakrar, Samantha J Zwiebel, Paul J Christine, et al.
Page
of 2